Page last updated: 2024-09-04
1-(2-chloroethyl)-3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl)-1-nitrosourea and Osteogenic Sarcoma
1-(2-chloroethyl)-3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl)-1-nitrosourea has been researched along with Osteogenic Sarcoma in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Berger, MR; Klenner, T; Rao, NU; Schmähl, D; Sosnovsky, G; Wingen, F | 1 |
Other Studies
1 other study(ies) available for 1-(2-chloroethyl)-3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl)-1-nitrosourea and Osteogenic Sarcoma
Article | Year |
---|---|
Evaluation of spin labeled TEPA and CCNU analogs against osteosarcoma and MNU-induced mammary carcinoma of the SD-rat.
Topics: Animals; Antineoplastic Agents; Azirines; Bone Neoplasms; Cyclic N-Oxides; Dose-Response Relationship, Drug; Ethylnitrosourea; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasm Transplantation; Nitrosourea Compounds; Osteosarcoma; Rats; Rats, Inbred Strains; Triethylenephosphoramide | 1989 |